Table 3.
Methodological quality of studies37
| A | Was the method of randomization adequate? | Y/N/DK |
| B | Was the treatment allocation concealed? | Y/N/DK |
| C | Were the groups similar at baseline regarding most prognostic indicators? | Y/N/DK |
| D | Was the patient blinded to the intervention? | Y/N/DK |
| E | Was the care provider blinded to the intervention? | Y/N/DK |
| F | Was the outcome assessor blinded to the intervention? | Y/N/DK |
| G | Were co-interventions avoided or comparable? | Y/N/DK |
| H | Was the compliance acceptable in all groups? | Y/N/DK |
| I | Was the dropout rate described and acceptable? | Y/N/DK |
| J | Was the timing of the outcome assessment in all groups similar? | Y/N/DK |
| K | Did the analysis include an intention-to-treat analysis? | Y/N/DK |
| L | Were there at least 10 participants? | Y/N/DK |
| M | Was there only one type of wound? | Y/N/DK |
| N | Was the duration of study at least 10 weeks? | Y/N/DK |
| O | Was the duration of study at least 4 weeks? | Y/N/DK |
| P | Was complete closure of all wounds achieved? | Y/N/DK |
DK, don't know; N, no; Y, yes.